Tower Research Capital (TRC)’s Loxo Oncology, Inc LOXO Stock Holding History

Tower Research Capital (TRC)’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-85	Closed	-$15K	–	4715
2018 Q3	$15K	Buy	+85	New	+$14.3K	﹤0.01%	2542
2017 Q4	–	Sell	-1,823	Closed	-$168K	–	4353
2017 Q3	$168K	Buy	+1,823	New	+$142K	0.01%	893
2017 Q1	–	Sell	-2,125	Closed	-$68K	–	4385
2016 Q4	$68K	Buy	+2,125	New	+$54.5K	0.01%	1212
2016 Q3	–	Sell	-100	Closed	-$2K	–	4959
2016 Q2	$2K	Sell	100 -100	-50%	-$2.49K	﹤0.01%	4048
2016 Q1	$5K	Buy	+200	New	+$4.18K	﹤0.01%	2799
2015 Q4	–	Sell	-953	Closed	-$17K	–	5400
2015 Q3	$17K	Buy	+953	New	+$18.6K	﹤0.01%	1905
2015 Q2	–	Sell	-62	Closed	-$1K	–	5353
2015 Q1	$1K	Buy	+62	New	+$772	﹤0.01%	4229

Other funds holding LOXO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tower Research Capital (TRC)'s LOXO Position: Q4 2018 in Review

Tower Research Capital (TRC) sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 85 shares — an estimated $15K sold.

Tower Research Capital (TRC) first reported a position in LOXO in Q1 2015 and held it in 7 quarters. The position peaked at $168K in Q3 2017. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

Tower Research Capital (TRC) reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
Tower Research Capital (TRC) sold 85 Loxo Oncology, Inc shares in Q4 2018, an estimated $15K.
Tower Research Capital (TRC) first reported a position in Loxo Oncology, Inc in Q1 2015 and held it in 7 quarters.
Tower Research Capital (TRC)'s Loxo Oncology, Inc position peaked at $168K in Q3 2017.
232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.